Join the Axitinib group to help and get support from people like you.
Axitinib News
Sustained Clinical Benefit Seen for Pembrolizumab + Axitinib in Advanced Renal Cancer
FRIDAY, Aug. 8, 2025 – For patients with advanced renal cell carcinoma (RCC), there is a sustained clinical benefit with pembrolizumab plus axitinib, according to a study published online Aug. 6 in...
FDA Approves Bavencio (avelumab) Plus Inlyta (axitinib) Combination for Patients with Advanced Renal Cell Carcinoma
Darmstadt, Germany and New York, US, May 14, 2019 – Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business as EMD Serono in the US and Canada, and Pfizer Inc. (NYSE: PFE) today ...